236 related articles for article (PubMed ID: 37435067)
21. Regulatory T cells subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis and treatment strategy in melanoma.
Huang W; Kim BS; Zhang Y; Lin L; Chai G; Zhao Z
Environ Toxicol; 2024 Mar; ():. PubMed ID: 38530049
[TBL] [Abstract][Full Text] [Related]
22. Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.
Konjević G; Mirjacić Martinović K; Vuletić A; Jović V; Jurisić V; Babović N; Spuzić I
Clin Exp Metastasis; 2007; 24(1):1-11. PubMed ID: 17295095
[TBL] [Abstract][Full Text] [Related]
23. Interdependence of sequential cytotoxic T lymphocyte and natural killer cell cytotoxicity against melanoma cells.
Friedmann KS; Kaschek L; Knörck A; Cappello S; Lünsmann N; Küchler N; Hoxha C; Schäfer G; Iden S; Bogeski I; Kummerow C; Schwarz EC; Hoth M
J Physiol; 2022 Dec; 600(23):5027-5054. PubMed ID: 36226443
[TBL] [Abstract][Full Text] [Related]
24. New avenues for melanoma immunotherapy: Natural Killer cells?
Cristiani CM; Garofalo C; Passacatini LC; Carbone E
Scand J Immunol; 2020 Apr; 91(4):e12861. PubMed ID: 31879979
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.
Messaoudene M; Périer A; Fregni G; Neves E; Zitvogel L; Cremer I; Chanal J; Sastre-Garau X; Deschamps L; Marinho E; Larousserie F; Maubec E; Avril MF; Caignard A
PLoS One; 2015; 10(7):e0133363. PubMed ID: 26218530
[TBL] [Abstract][Full Text] [Related]
26. PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling.
Raja R; Wu C; Bassoy EY; Rubino TE; Utagawa EC; Magtibay PM; Butler KA; Curtis M
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36564125
[TBL] [Abstract][Full Text] [Related]
27. Defective Natural Killer Cells in Melanoma: Role of NKG2D in Pathogenesis and Immunotherapy.
Touboul R; Zaravinos A; Bonavida B
Crit Rev Immunol; 2021; 41(2):45-76. PubMed ID: 34348002
[TBL] [Abstract][Full Text] [Related]
28. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
[TBL] [Abstract][Full Text] [Related]
29. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
[TBL] [Abstract][Full Text] [Related]
30. Visualization and quantification of NK cell-mediated cytotoxicity over extended time periods by image cytometry.
Chan LL; Wucherpfennig KW; de Andrade LF
J Immunol Methods; 2019 Jun; 469():47-51. PubMed ID: 30951701
[TBL] [Abstract][Full Text] [Related]
31. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
Markovic SN; Murasko DM
Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166
[TBL] [Abstract][Full Text] [Related]
32. IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma.
Frederiksen KS; Lundsgaard D; Freeman JA; Hughes SD; Holm TL; Skrumsager BK; Petri A; Hansen LT; McArthur GA; Davis ID; Skak K
Cancer Immunol Immunother; 2008 Oct; 57(10):1439-49. PubMed ID: 18286285
[TBL] [Abstract][Full Text] [Related]
33. CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation.
Reyes RM; Zhang C; Deng Y; Ji N; Mukherjee N; Padron AS; Clark CA; Svatek RS; Curiel TJ
Oncoimmunology; 2021; 10(1):2006529. PubMed ID: 34858732
[TBL] [Abstract][Full Text] [Related]
34. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
[TBL] [Abstract][Full Text] [Related]
35. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
[No Abstract] [Full Text] [Related]
36. Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion.
Freeman AJ; Vervoort SJ; Ramsbottom KM; Kelly MJ; Michie J; Pijpers L; Johnstone RW; Kearney CJ; Oliaro J
Cell Rep; 2019 Sep; 28(11):2784-2794.e5. PubMed ID: 31509742
[TBL] [Abstract][Full Text] [Related]
37. Activated mouse CD4(+)Foxp3(-) T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity.
Wang X; Cui Y; Luo G; Wang Q; Hu J; He W; Yuan J; Zhou J; Wu Y; Sun X; Robson SC; Li X; Tan J; Peng Y; Xue G; Lu L; Gao W; Wu J
Cell Res; 2012 Dec; 22(12):1696-706. PubMed ID: 22945357
[TBL] [Abstract][Full Text] [Related]
38. Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural killer cell activity.
Neelam S; Mellon J; Wilkerson A; Niederkorn JY
Melanoma Res; 2019 Aug; 29(4):401-412. PubMed ID: 30932943
[TBL] [Abstract][Full Text] [Related]
39. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.
Carrega P; Pezzino G; Queirolo P; Bonaccorsi I; Falco M; Vita G; Pende D; Misefari A; Moretta A; Mingari MC; Moretta L; Ferlazzo G
PLoS One; 2009 Dec; 4(12):e8132. PubMed ID: 19997637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
